506 filings
Page 3 of 26
SC 13G/A
g5rfzp
14 Feb 23
Minerva Neurosciences / Point72 Asset Management ownership change
12:00am
SC 13G/A
dao0 hpxtsd7jstks9
9 Feb 23
Minerva Neurosciences / VANGUARD ownership change
11:27am
SC 13G/A
pxuausz5
1 Feb 23
Minerva Neurosciences / FEDERATED HERMES ownership change
11:16am
8-K
4opfdyxmd3 4n11p79k
28 Dec 22
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
8:24am
8-K
0fu 9cq0k7wv257nfw
16 Dec 22
Departure of Directors or Certain Officers
4:31pm
4
1b1ee 9ddb47pql
14 Dec 22
Minerva Neurosciences / Remy Luthringer ownership change
4:50pm
4
lnaavx2n
14 Dec 22
Minerva Neurosciences / Geoff Race ownership change
4:48pm
4
ngdn660l2
14 Dec 22
Minerva Neurosciences / Frederick W Ahlholm ownership change
4:47pm
8-K
063bj tbq
2 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
xc18c fw4c3
17 Oct 22
Other Events
8:37am
EFFECT
og86qh
26 Sep 22
Notice of effectiveness
12:15am
UPLOAD
mq9 tk4t2zateq0lff
21 Sep 22
Letter from SEC
12:00am
UPLOAD
wfr09
21 Sep 22
Letter from SEC
12:00am
CORRESP
4nwt0beitgk0
21 Sep 22
Correspondence with SEC
12:00am
CORRESP
ocxspskd
14 Sep 22
Correspondence with SEC
12:00am
UPLOAD
2tyuw6 8uw1m
12 Sep 22
Letter from SEC
12:00am
8-K
tjvobrtcu 9ooiy36m6
9 Sep 22
Minerva Neurosciences Announces Listing Transfer to Nasdaq Capital Market
4:30pm